TheraRadar
← Back
Data updated: Jul 17, 2026

HI-TECH PHARMACAL

Pharma

HI-TECH PHARMACAL is a pharmaceutical company focused on Infectious Disease.

-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

HI-TECH PHARMACAL's Key Drugs

HI-TECH PHARMACAL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

HI-TECH PHARMACAL's Recent FDA Approvals

New NDA/BLA approvals for HI-TECH PHARMACAL over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

HI-TECH PHARMACAL's Therapeutic Areas

HI-TECH PHARMACAL's approved drugs and pipeline span 1 therapeutic area, led by Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Infectious Disease 100%
1 drugs

HI-TECH PHARMACAL's Top Competitors

HI-TECH PHARMACAL's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

HI-TECH PHARMACAL Pipeline Snapshot

Active clinical trials for HI-TECH PHARMACAL across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Infectious Disease pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling